Aug. 21 at 5:35 PM
$VERU I was wondering if Novo had any type of muscle preservation drug and so far I have not found anything yet. With that said I did come across the following Lexicon Deal. Keep in mind Lexicon drug was only tested in mice and many of the mice studies do not show the same results in people. Plus it takes time to go from mice to people as far a drug development times.
The Danish drugmaker is betting
$75 million in upfront and near-term milestone payments to secure global rights to a preclinical prospect that paired well with its GLP-1 blockbuster semaglutide in mice.
The upfront and near-term payments form part of a total package that could be worth
$1 billion, plus royalties, if the deal meets all its development, regulatory and sales milestones, though with the normal caveats that this is still very early stage and has a lot to prove in the clinic.
Full Article:
https://www.fiercebiotech.com/biotech/novo-inks-1b-lexicon-obesity-deal-after-seeing-preclinical-prospect-shine-semaglutide
